The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition
- 31 August 2011
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 61 (1-2), 95-104
- https://doi.org/10.1016/j.neuropharm.2011.03.007
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self‐administrationSynapse, 2010
- Rodent models of nicotine reward: What do they tell us about tobacco abuse in humans?Pharmacology Biochemistry and Behavior, 2009
- Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in ratsEuropean Journal of Pharmacology, 2008
- Prenatal nicotine exposure changes natural and drug‐induced reinforcement in adolescent male ratsEuropean Journal of Neuroscience, 2008
- The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in ratsBehavioural Pharmacology, 2007
- Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in RatsJournal of Pharmacology and Experimental Therapeutics, 2007
- Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in ratsEuropean Journal of Neuroscience, 2006
- Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in miceEuropean Journal of Neuroscience, 2006
- Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to NicotineNeuropsychopharmacology, 2005
- Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in RatsJournal of Neuroscience, 2005